These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21748859)

  • 21. The syntheses of 1-(2-thienyl)-2-(methylamino) propane (methiopropamine) and its 3-thienyl isomer for use as reference standards.
    Angelov D; O'Brien J; Kavanagh P
    Drug Test Anal; 2013 Mar; 5(3):145-9. PubMed ID: 21770051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging toxicity of 5,6-methylenedioxy-2-aminoindane (MDAI): Pharmacokinetics, behaviour, thermoregulation and LD50 in rats.
    Páleníček T; Lhotková E; Žídková M; Balíková M; Kuchař M; Himl M; Mikšátková P; Čegan M; Valeš K; Tylš F; Horsley RR
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():49-59. PubMed ID: 27083855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behavioral and Pharmacokinetics Studies of
    Tirri M; Corli G; Arfè R; Marchetti B; Bilel S; Bernardi T; Boccuto F; Odoardi S; Mestria S; Strano-Rossi S; Marti M
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones.
    Brandt SD; Freeman S; Sumnall HR; Measham F; Cole J
    Drug Test Anal; 2011 Sep; 3(9):569-75. PubMed ID: 21960541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects: a review of case reports and preclinical findings.
    Zanda MT; Fadda P; Chiamulera C; Fratta W; Fattore L
    Behav Pharmacol; 2016 Sep; 27(6):489-96. PubMed ID: 27128862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A chemical analysis examining the pharmacology of novel psychoactive substances freely available over the internet and their impact on public (ill)health. Legal highs or illegal highs?
    Ayres TC; Bond JW
    BMJ Open; 2012; 2(4):. PubMed ID: 22855623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An analysis of legal highs: do they contain what it says on the tin?
    Baron M; Elie M; Elie L
    Drug Test Anal; 2011 Sep; 3(9):576-81. PubMed ID: 21595051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential utility of some legal highs in CNS disorders.
    Davidson C; Schifano F
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():267-74. PubMed ID: 26232510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microcrystalline identification of selected designer drugs.
    Elie L; Baron M; Croxton R; Elie M
    Forensic Sci Int; 2012 Jan; 214(1-3):182-8. PubMed ID: 21889275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The synthesis and characterization N-methyl-3-phenyl-norbornan-2-amine (Camfetamine™).
    Kavanagh P; Angelov D; O'Brien J; Power JD; McDermott SD; Talbot B; Fox J; O'Donnell C; Christie R
    Drug Test Anal; 2013 Apr; 5(4):247-53. PubMed ID: 22374810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Legal Highs"--An Emerging Epidemic of Novel Psychoactive Substances.
    Zawilska JB
    Int Rev Neurobiol; 2015; 120():273-300. PubMed ID: 26070762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP).
    Wood DM; Dargan PI
    Clin Toxicol (Phila); 2012 Sep; 50(8):727-32. PubMed ID: 22882169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation of dimeric 1,2,3,4-tetrahydro-naphthalenylamine and indan-1-ylamine derivatives with mast cell-stabilising and anti-allergic activity.
    Barlow JW; Walsh JJ
    Eur J Med Chem; 2010 Jan; 45(1):25-37. PubMed ID: 19800715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and co-existence of active components of 'legal highs'.
    Zuba D; Byrska B
    Drug Test Anal; 2013 Jun; 5(6):420-9. PubMed ID: 22549997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Khat and synthetic cathinones: a review.
    Valente MJ; Guedes de Pinho P; de Lourdes Bastos M; Carvalho F; Carvalho M
    Arch Toxicol; 2014 Jan; 88(1):15-45. PubMed ID: 24317389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural product 'legal highs'.
    Arunotayanun W; Gibbons S
    Nat Prod Rep; 2012 Nov; 29(11):1304-16. PubMed ID: 22930322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Buying 'legal' recreational drugs does not mean that you are not breaking the law.
    Ramsey J; Dargan PI; Smyllie M; Davies S; Button J; Holt DW; Wood DM
    QJM; 2010 Oct; 103(10):777-83. PubMed ID: 20675395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of the prohibition of benzylpiperazine (BZP) 'legal highs' on the prevalence of BZP, new legal highs and other drug use in New Zealand.
    Wilkins C; Sweetsur P
    Drug Alcohol Depend; 2013 Jan; 127(1-3):72-80. PubMed ID: 22819869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ["Legal highs" from the German internet--"bath salt drugs" on the rise].
    Musshoff F; Hottmann L; Hess C; Madea B
    Arch Kriminol; 2013; 232(3-4):91-103. PubMed ID: 24358620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 'Ivory wave' toxicity in recreational drug users; integration of clinical and poisons information services to manage legal high poisoning.
    Murray DB; Potts S; Haxton C; Jackson G; Sandilands EA; Ramsey J; Puchnarewicz M; Holt DW; Johnston A; Nicholas Bateman D; Dear JW
    Clin Toxicol (Phila); 2012 Feb; 50(2):108-13. PubMed ID: 22224933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.